These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9027185)

  • 1. [The problem of designing typhoid vaccines].
    Tymchuk SN; Boĭchenko MN; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):86-90. PubMed ID: 9027185
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence and immunogenicity of galactose-resistant variants of Salmonella typhi Ty21a.
    Saxena M; Percheson PB; Di Fabio JL
    J Infect Dis; 1993 Aug; 168(2):522-3. PubMed ID: 8336003
    [No Abstract]   [Full Text] [Related]  

  • 4. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages.
    Hall CB
    Pediatrics; 1995 Aug; 96(2 Pt 1):348-50. PubMed ID: 7630698
    [No Abstract]   [Full Text] [Related]  

  • 5. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in vaccines for typhoid fever.
    Gupta A; Jalla S; Sazawal S; Bhan MK
    Indian J Pediatr; 1994; 61(4):321-39. PubMed ID: 8002060
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization against typhoid: a short review.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1994 May; 42(5):424. PubMed ID: 7829448
    [No Abstract]   [Full Text] [Related]  

  • 8. Typhoid immunisation.
    Ghai OP; Paul VK
    Indian J Pediatr; 1984; 51(408):71-6. PubMed ID: 6378786
    [No Abstract]   [Full Text] [Related]  

  • 9. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
    Pulickal AS; Pollard AJ
    Expert Rev Vaccines; 2007 Jun; 6(3):293-5. PubMed ID: 17542742
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response of infants and preschool children to typhoid vaccine given intradermally or subcutaneously.
    Mohandas V; Cherian T; Sridharan G; Simoes EA; Pereira SM; John TJ
    BMJ; 1989 Jan; 298(6667):162-3. PubMed ID: 2493838
    [No Abstract]   [Full Text] [Related]  

  • 12. A Salmonella typhi Vi conjugate vaccine.
    Koul PA
    N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.
    Arya SC
    Vaccine; 1997 Feb; 15(2):244. PubMed ID: 9066045
    [No Abstract]   [Full Text] [Related]  

  • 14. [A chemical typhoid vaccine containing a surface-antigen complex including the K-antigen].
    Stepanova LK; Belaia IuA; Sergeeva NS; Ageeva VA; Petrukhin VG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):51-6. PubMed ID: 7520650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
    Tacket CO; Levine MM; Robbins JB
    Vaccine; 1988 Aug; 6(4):307-8. PubMed ID: 3188615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against intracellular bacterial pathogens.
    Pang T
    Trends Microbiol; 1998 Nov; 6(11):433. PubMed ID: 9846359
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.
    Kim YR; Yoo JH; Hur JK; Kang JH; Shin WS; Kang MW
    J Korean Med Sci; 1995 Oct; 10(5):314-7. PubMed ID: 8750055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply.
    Keddy KH; Klugman KP; Robbins JB
    Vaccine; 1998; 16(9-10):871-2. PubMed ID: 9682329
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.